Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-05

Clinical Trial Update: Pre-exposure Option for Reducing HIV in the UK.(PROUD) [Phase 4]

View source ↗

Summary

Phase 4 PROUD trial update reporting completion of a pre-exposure prophylaxis study in the UK to reduce HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: MRC [ycm] | Conditions: HIV | Phase 4 | Status: COMPLETED